Skip to main content

Tower Research Capital LLC (TRC)

Position in DNLI — Denali Therapeutics Inc.

CIK 1533421 NEW YORK, NY

Position in DNLI

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$293,027
-$109,750 QoQ
Shares Held
11,393
-45.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#184
of 290 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,473,308 across 466 Biotechnology names. DNLI ranks #32 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $293,027 11,393
2026-03-31 $402,777 20,978
2025-12-31 $213,655 12,941
2025-09-30 $107,098 7,376
2025-06-30 $191,228 13,669
2025-03-31 $43,667 3,212
2024-12-31 $230,048 11,288
2024-09-30 $12,555 431
2024-06-30 $483,719 20,832
2024-03-31 $29,241 1,425
2023-12-31 $122,836 5,724
2023-09-30 $35,235 1,708
2023-06-30 $176,764 5,990
2023-03-31 $92,275 4,005
2022-12-31 $42,578 1,554
2022-09-30 $436,288 14,216
2022-06-30 $309,485 10,516
2022-03-31 $67,460 2,097
2021-12-31 $327,319 7,339
2021-09-30 $273,186 5,415
2021-06-30 $355,097 4,527
2021-03-31 $437,500 7,662
2020-12-31 $338,139 4,037
2020-09-30 $82,623 2,306
2020-06-30 $231,668 9,581